Join
Live feed
·
INSIDERFilingvia Quantisnow
Aadi Bioscience Inc. logo

Officer Ball Bryan converted options into 5,000 shares, sold $5,045 worth of shares (2,147 units at $2.35) and was granted 100,000 shares, increasing direct ownership by 103% to 202,853 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AADI (Aadi Bioscience Inc.) and more on Quantisnow.